newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors

LONDON, May 04, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of Bernhard Ehmer, MD, to the Boar